Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Prenetics Group ( (PRE) ) has issued an announcement.
On November 12, 2025, Prenetics Global Limited’s Chief Marketing Officer, Rahul Ramchand, purchased 30,000 shares of the company’s Class A Ordinary Shares at $13.17 each, totaling $395,151. This acquisition increases his total holdings to 45,553 shares, signaling confidence in the company’s future prospects and potentially impacting investor sentiment positively.
The most recent analyst rating on (PRE) stock is a Hold with a $12.50 price target. To see the full list of analyst forecasts on Prenetics Group stock, see the PRE Stock Forecast page.
Spark’s Take on PRE Stock
According to Spark, TipRanks’ AI Analyst, PRE is a Neutral.
The overall stock score is primarily influenced by financial performance challenges, including negative profitability and cash flow issues. Technical analysis shows mixed signals, while valuation is negatively impacted by a lack of earnings and dividends. These factors collectively suggest caution for potential investors.
To see Spark’s full report on PRE stock, click here.
More about Prenetics Group
Prenetics Global Limited is a leading health sciences company known for its premium health and longevity brand, IM8. The company is focused on advancing health sciences and providing innovative health solutions.
Average Trading Volume: 134,328
Technical Sentiment Signal: Buy
Current Market Cap: $195.6M
Learn more about PRE stock on TipRanks’ Stock Analysis page.